Come up with a name for your new list and we'll add to it:
RemAb Therapeutics raised a round of funding on August 09, 2018. Investors include
European Institute of Innovation and Technology.
RemAb is developing an advanced medical solution to prevent nosocomial infections by Gram-negative bacteria. The treatment is based on the systemic elimination of inhibitory natural anti-glycan antibo…